On May 6, 2024, Assure Holdings Corp. (NASDAQ: IONM), a provider of intraoperative neuromonitoring and remote neurology services, issued a press release urging its stockholders to vote in favor of a proposal to increase the number of authorized common shares from 9,000,000 to 250,000,000. The special meeting of stockholders is scheduled for May 14, 2024. The company has already received a favorable response, with over 95% of votes cast supporting the proposal. However, more votes are needed to reach the required 50% of outstanding shares for approval. CEO John Farlinger emphasized the importance of each vote, including those from stockholders with smaller positions. The increase in authorized shares is deemed critical for the company's capital needs. Assure has filed a definitive proxy statement with the SEC, and the documents are available on both the company's and SEC's websites. The proposed increase is part of a larger transaction with Danam Health Inc., which includes a merger and the combined company's listing on Nasdaq. The transaction is subject to stockholder approval and other customary closing conditions.

On May 6, 2024, Assure Holdings Corp. (NASDAQ: IONM), a provider of intraoperative neuromonitoring and remote neurology services, issued a press release urging its stockholders to vote in favor of a proposal to increase the number of authorized common shares from 9,000,000 to 250,000,000. The special meeting of stockholders is scheduled for May 14, 2024. The company has already received a favorable response, with over 95% of votes cast supporting the proposal. However, more votes are needed to reach the required 50% of outstanding shares for approval. CEO John Farlinger emphasized the importance of each vote, including those from stockholders with smaller positions. The increase in authorized shares is deemed critical for the company's capital needs. Assure has filed a definitive proxy statement with the SEC, and the documents are available on both the company's and SEC's websites. The proposed increase is part of a larger transaction with Danam Health Inc., which includes a merger and the combined company's listing on Nasdaq. The transaction is subject to stockholder approval and other customary closing conditions.